In prostate cancer, Peehl et al. noted that there is a high expression of MAO-A in patients with a high tumor grade [23]; the targeting of antidepression drugs on MAO-A may provide potential future applications in the treatment of prostate cancer [24]. This evidence concerns the gene MAOA and neoplasm.